Key Points
Protective HLA alleles in HIV infection recruit biased T cell repertoires.
The T cell repertoire is highly similar between different rates of HIV progression.
Abstract
CD8+ T cells play an important role in the control of untreated HIV infection. Several studies have suggested a decisive role of TCRs involved in anti-HIV immunity. HLA-B*27 and B*57 are often associated with a delayed HIV disease progression, but the exact correlates that provide superior immunity against HIV are not known. To investigate if the T cell repertoire underlies the protective effect in disease outcome in HLA-B*27 and B*57+ individuals, we analyzed Ag-specific TCR profiles from progressors (n = 13) and slow progressors (n = 11) expressing either B*27 or B*57. Our data showed no differences in TCR diversity between progressors and slow progressors. Both alleles recruit biased T cell repertoires (i.e., TCR populations skewed toward specific TRBV families or CDR3 regions). This bias was unrelated to disease progression and was remarkably profound for HLA-B*57, in which TRBV family usage and CDR3 sequences were shared to some extent even between epitopes. Conclusively, these data suggest that the T cell repertoires recruited by protective HLA alleles are highly similar between progressors and slow progressors in terms of TCR diversity, TCR usage, and cross-reactivity.
Footnotes
This work was supported by a grant from the AIDS Funds from the Netherlands (2011033).
D.K. performed experimental work, analyzed data, and has written the manuscript. E.D.Q. performed experimental work. I.M.M.S. analyzed data and assisted in preparation of the manuscript. E.S. assisted in deep-sequence TCR analysis and manuscript preparation. D.v.B. designed and supervised the study and has written the manuscript.
The online version of this article contains supplemental material.
Abbreviations used in this article
- HPS
- human pool serum
- MHCI
- MHC class I
- P
- position
- pMHC
- peptide–MHC
- RH10
- RPMI-1640 containing 10% HPS and 1% antibiotics
- WT
- wild-type
- Received October 9, 2020.
- Accepted November 1, 2021.
- Copyright © 2021 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.